NASDAQ:CORT
$24.32
(
-0.613%
)
Friday, 3rd Feb 2023
Corcept Therapeutics Incorporated Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $19.78 | $24.87 | Friday, 3rd Feb 2023 CORT stock ended at $24.32. This is 0.613% less than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 3.93% from a day low at $23.93 to a day high of $24.87. |
| 90 days | $19.59 | $27.38 | |
| 52 weeks | $17.19 | $30.14 |
Historical Corcept Therapeutics Incorporated prices
| Date | Open | High | Low | Close | Volume |
| 2023-02-03 | $24.37 | $24.87 | $23.93 | $24.32 | 611 775 |
| 2023-02-02 | $24.03 | $24.74 | $23.80 | $24.47 | 759 344 |
| 2023-02-01 | $22.86 | $24.13 | $22.65 | $23.94 | 1 091 116 |
| 2023-01-31 | $23.07 | $23.35 | $22.77 | $22.86 | 476 475 |
| 2023-01-30 | $23.26 | $23.40 | $22.98 | $22.99 | 416 724 |
| 2023-01-27 | $22.96 | $23.45 | $22.90 | $23.26 | 270 345 |
| 2023-01-26 | $23.58 | $23.84 | $22.85 | $22.94 | 404 347 |
| 2023-01-25 | $22.73 | $23.39 | $22.29 | $23.38 | 639 002 |
| 2023-01-24 | $24.18 | $24.26 | $22.36 | $22.77 | 1 010 472 |
| 2023-01-23 | $24.00 | $24.27 | $23.64 | $24.17 | 581 694 |
| 2023-01-20 | $23.82 | $23.98 | $23.34 | $23.93 | 642 200 |
| 2023-01-19 | $23.50 | $23.79 | $23.27 | $23.68 | 649 700 |
| 2023-01-18 | $22.93 | $23.86 | $22.93 | $23.49 | 770 316 |
| 2023-01-17 | $22.42 | $23.02 | $22.28 | $22.93 | 575 500 |
| 2023-01-13 | $21.93 | $22.79 | $21.93 | $22.44 | 879 984 |
| 2023-01-12 | $21.15 | $21.88 | $20.81 | $21.86 | 704 939 |
| 2023-01-11 | $20.93 | $21.12 | $20.77 | $21.02 | 489 537 |
| 2023-01-10 | $20.55 | $21.03 | $20.55 | $20.89 | 386 300 |
| 2023-01-09 | $20.66 | $20.82 | $20.43 | $20.52 | 441 324 |
| 2023-01-06 | $20.71 | $20.93 | $20.35 | $20.64 | 521 600 |
| 2023-01-05 | $20.09 | $20.63 | $19.78 | $20.50 | 469 104 |
| 2023-01-04 | $20.23 | $20.56 | $19.81 | $20.24 | 610 363 |
| 2023-01-03 | $20.40 | $20.65 | $19.97 | $20.17 | 659 704 |
| 2022-12-30 | $20.36 | $20.37 | $20.01 | $20.31 | 528 516 |
| 2022-12-29 | $20.12 | $20.59 | $20.03 | $20.48 | 463 231 |
| 2022-12-28 | $20.07 | $20.31 | $19.87 | $19.95 | 362 520 |
| 2022-12-27 | $20.64 | $20.65 | $19.84 | $20.01 | 466 504 |
| 2022-12-23 | $20.66 | $20.97 | $20.45 | $20.65 | 523 332 |
| 2022-12-22 | $20.50 | $20.78 | $20.20 | $20.60 | 640 636 |
| 2022-12-21 | $20.61 | $20.68 | $20.19 | $20.56 | 519 145 |
| 2022-12-20 | $20.26 | $20.95 | $20.26 | $20.52 | 1 403 739 |
| 2022-12-19 | $20.10 | $20.80 | $20.10 | $20.30 | 1 059 258 |
| 2022-12-16 | $20.07 | $20.39 | $19.59 | $20.09 | 2 539 096 |
| 2022-12-15 | $20.51 | $20.67 | $20.02 | $20.18 | 1 868 347 |
| 2022-12-14 | $20.78 | $21.01 | $20.51 | $20.65 | 936 576 |
| 2022-12-13 | $21.43 | $21.43 | $20.75 | $20.86 | 1 534 335 |
| 2022-12-12 | $21.64 | $21.83 | $20.61 | $20.84 | 1 412 679 |
| 2022-12-09 | $22.97 | $22.97 | $21.31 | $21.38 | 1 552 402 |
| 2022-12-08 | $23.48 | $23.56 | $22.64 | $23.01 | 957 936 |
| 2022-12-07 | $22.92 | $23.60 | $22.75 | $23.52 | 487 582 |
| 2022-12-06 | $23.41 | $23.52 | $22.53 | $22.86 | 1 295 150 |
| 2022-12-05 | $24.75 | $24.91 | $23.22 | $23.40 | 1 924 317 |
| 2022-12-02 | $24.82 | $25.16 | $24.67 | $24.98 | 301 902 |
| 2022-12-01 | $25.27 | $25.29 | $24.64 | $24.94 | 536 199 |
| 2022-11-30 | $25.68 | $25.72 | $24.84 | $25.28 | 821 556 |
| 2022-11-29 | $25.32 | $25.62 | $25.16 | $25.56 | 295 608 |
| 2022-11-28 | $25.92 | $25.92 | $25.25 | $25.37 | 375 837 |
| 2022-11-25 | $26.02 | $26.29 | $26.01 | $26.10 | 86 883 |
| 2022-11-23 | $26.06 | $26.34 | $25.38 | $25.99 | 322 071 |
| 2022-11-22 | $25.94 | $26.07 | $25.40 | $26.04 | 406 601 |
About Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have ... CORT Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
